袁炜

    【摘要】目的：分析腹瀉患者粪便标本细菌培养鉴定及药敏情况。方法：就本院治疗且符合研究标准的腹泻患者中选取540例为探究主体，研究日期是2020年1月—2022年3月，全部患者均实施粪便标本细菌培养鉴定，以常规粪便培养法鉴定，同时进行药敏试验，对于鉴定结果进行分析。结果：经对540例腹泻患者粪便标本细菌培养鉴定结果实施分析发现，共检出71例阳性，阳性检出率为13.15%，其中痢疾志贺氏菌有27例，占比为38.03%，致病性大肠埃希菌为22例，占比为30.99%，肠球菌属有9例，占比为12.68%，克雷伯菌属有6例，占比为8.45%，变形杆菌有5例，占比为7.04%，真菌有2例，占比为2.82%。对于排名前2名致病菌药敏结果分析发现，痢疾志贺氏菌对于头孢噻肟的耐药性最高，为81.48%，其次是头孢哌酮、环丙沙星、庆大霉素、阿莫西林、复方新诺明；致病性大肠埃希菌对于头孢噻肟的耐药性最高，为86.36%，其次是环丙沙星、阿莫西林、头孢哌酮、庆大霉素、复方新诺明。结论：造成腹泻的致病菌较多，主要是痢疾志贺氏菌和致病性大肠埃希菌，近年来随着抗菌药物的大量使用，导致菌株耐药性不断升高，为有效治疗腹泻患者，临床需积极开展粪便标本细菌培养鉴定与药敏试验，以便于准确、高效用药。

    【关键词】粪便标本细菌培养鉴定；腹泻；药敏

    Drug susceptibility analysis of fecal specimen bacterial culture identification in patients with diarrhea

    YUAN Wei

    Ningshan County Hospital， Ankang， Shaanxi 711699， China

    【Abstract】Objective： To analyze the bacterial culture identification and drug susceptibility of stool samples from patients with diarrhea. Methods： A total of 540 cases of diarrhea patients who were treated in our hospital and met the research criteria were selected as the main body of research. The study period was from January 2020 to March 2022. All patients were identified by fecal specimen bacterial culture and method was conventional fecal culture ......